M12-PMO

N/A

Report date: 2025/04/21 17:03:48

NME

Base Information

Drug NameM12-PMO

Drug Alias NameM12-PMO

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Peptide-oligonucleotide ConjugateSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) > Peptide-oligonucleotide Conjugate

Mechanisms of ActionDystrophin expression stimulants

TargetsDystrophin

Therapy Area/IndicationsMuscular Dystrophy, Duchenne

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaPending

Originator CompaniesTianjin Medical University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTianjin Medical University

Active IndicationsN/A

Inactive IndicationsMuscular Dystrophy, Duchenne

Other Information

ATC CodeN/A